Sign in to view content

Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial

Philip J. Ferrone, MD, FASRS

Video
Published 2019

Phillip J. Ferrone, MD

AMD Neovascular Part I Symposium

Related

Endophthalmitis Rates After Bilateral Same Day Intravitreal Anti-VEGF Injections
Durga Borkar, MD
Updates from the Field
2018
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First-Time 26-Week Interim Analysis Results From the Phase 2 LUNA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2024

Category: AMD-Neovascular

See more